The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover

Psychoneuroendocrinology

Volumn 36, Issue 3, 2011, Pages 339-351

  Branchi, Igor ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

5 HTTLPR; Adaptive phenotypic plasticity; Antidepressant; Biological sensitivity to context; Environment; Major depression; Mood disorder; Serotonin transporter; SSRE; SSRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; COPING BEHAVIOR; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MECHANISM; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SUICIDE;

ANIMALS; DEPRESSION; DISEASE SUSCEPTIBILITY; HUMANS; MODELS, BIOLOGICAL; NEURONAL PLASTICITY; PROGNOSIS; RECOVERY OF FUNCTION; SEROTONIN; UP-REGULATION;

EID: 79951955926     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.08.011     Document Type: Article

References (133)

1. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol. Psychiatry 2006, 59:244-251.
2. Anstey M.L., Rogers S.M., Ott S.R., Burrows M., Simpson S.J. Serotonin mediates behavioral gregarization underlying swarm formation in desert locusts. Science 2009, 323:627-630.
3. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 1999, 21:33S-45S.
4. Balak N., Elmaci I. Costs of disorders of the brain in Europe. Eur. J. Neurol. 2007, 14:e9.
5. Barbui C., Esposito E., Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 2009, 180:291-297.
6. Barr C.S., Newman T.K., Becker M.L., Parker C.C., Champoux M., Lesch K.P., Goldman D., Suomi S.J., Higley J.D. The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav. 2003, 2:336-340.
7. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008, 358:55-68.
8. Belsky J. Differential susceptibility to rearing influences: an evolutionary hypothesis and some evidence. Origins of the Social Mind: Evolutionary Psychology and Child Development 2005, 139-163. Guildford, New York. B.J. Ellis, D. Bjorklund (Eds.).
9. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes? Mol. Psychiatry 2009, 14:746-754.
10. Benedetti F., Barbini B., Lucca A., Campori E., Colombo C., Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur. Arch. Psychiatry Clin. Neurosci. 1997, 247:100-103.
11. Berardi N., Pizzorusso T., Ratto G.M., Maffei L. Molecular basis of plasticity in the visual cortex. Trends Neurosci. 2003, 26:369-378.
12. Bessa J.M., Ferreira D., Melo I., Marques F., Cerqueira J.J., Palha J.A., Almeida O.F., Sousa N. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol. Psychiatry 2009, 14:764-773. 739.
13. Boyce W.T., Ellis B.J. Biological sensitivity to context: I. An evolutionary-developmental theory of the origins and functions of stress reactivity. Dev. Psychopathol. 2005, 17:271-301.
14. Boyce W.T., O'Neill-Wagner P., Price C.S., Haines M., Suomi S.J. Crowding stress and violent injuries among behaviorally inhibited rhesus macaques. Health Psychol. 1998, 17:285-289.
15. Branchi I., D'Andrea I., Cirulli F., Lipp H.P., Alleva E. Shaping brain development: mouse communal nesting blunts adult neuroendocrine and behavioral response to social stress and modifies chronic antidepressant treatment outcome. Psychoneuroendocrinology 2010, 35:743-751.
16. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157:115-118.
17. Brown G.W., Harris T.O., Kendrick T., Chatwin J., Craig T.K., Kelly V., Mander H., Ring A., Wallace V., Uher R. Antidepressants, social adversity and outcome of depression in general practice. J. Affect. Disord. 2010, 121:239-246.
18. Brummett B.H., Boyle S.H., Siegler I.C., Kuhn C.M., Ashley-Koch A., Jonassaint C.R., Zuchner S., Collins A., Williams R.B. Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav. Genet. 2008, 38:34-43.
19. Cameron N.M., Shahrokh D., Del Corpo A., Dhir S.K., Szyf M., Champagne F.A., Meaney M.J. Epigenetic programming of phenotypic variations in reproductive strategies in the rat through maternal care. J. Neuroendocrinol. 2008, 20:795-801.
20. Canli T., Lesch K.P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 2007, 10:1103-1109.
21. Canli T., Qiu M., Omura K., Congdon E., Haas B.W., Amin Z., Herrmann M.J., Constable R.T., Lesch K.P. Neural correlates of epigenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16033-16038.
22. Carroll J.C., Boyce-Rustay J.M., Millstein R., Yang R., Wiedholz L.M., Murphy D.L., Holmes A. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav. Genet. 2007, 37:214-222.
23. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 2006, 7:583-590.
24. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
25. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
26. Castren E. Is mood chemistry? Nat. Rev. Neurosci. 2005, 6:241-246.
27. Charney D.S. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 2004, 161:195-216.
28. Chourbaji S., Brandwein C., Vogt M.A., Dormann C., Hellweg R., Gass P. Nature vs. nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice? Behav. Brain Res. 2008, 192:254-258.
29. Clapp W.C., Zaehle T., Lutz K., Marcar V.L., Kirk I.J., Hamm J.P., Teyler T.J., Corballis M.C., Jancke L. Effects of long-term potentiation in the human visual cortex: a functional magnetic resonance imaging study. Neuroreport 2005, 16:1977-1980.
30. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., Arranz M.J., Murray R.M., Vallada H.P., Bengel D., Muller C.R., Roberts G.W., Smeraldi E., Kirov G., Sham P., Lesch K.P. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol. Psychiatry 1996, 1:453-460.
31. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 2001, 58:545-553.
32. Crawford C.B., Anderson J.L. Sociobiology: an environmentalist discipline? Am. Psychol. 1989, 44:1449-1459.
33. Cuijpers P., Dekker J., Hollon S.D., Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J. Clin. Psychiatry 2009, 70:1219-1229.
34. Curley J.P., Branchi I. Ontogeny of stable individual differences: gene-environment and epigenetic mechanisms. Animal Personalities: Behavior, Physiology and Evolution 2010, Chicago University Press, Chicago. D. Meastripieri, C. Carere (Eds.).
35. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12796-12801.
36. DeRubeis R.J., Siegle G.J., Hollon S.D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 2008, 9:788-796.
37. Dohrenwend B.P., Dohrenwend B.S. Social and cultural influences on psychopathology. Annu. Rev. Psychol. 1974, 25:417-452.
38. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
39. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54:597-606.
40. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 2000, 48:732-739.
41. Eaton W.W. Life events, social supports, and psychiatric symptoms: a re-analysis of the New Haven data. J. Health Soc. Behav. 1978, 19:230-234.
42. Eley T.C., Sugden K., Corsico A., Gregory A.M., Sham P., McGuffin P., Plomin R., Craig I.W. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry 2004, 9:908-915.
43. Ellis B.J., Boyce W.T. Biological sensitivity to context. Curr. Direct. Psychol. Sci. 2008, 17:183-187.
44. Ellis B.J., Essex M.J., Boyce W.T. Biological sensitivity to context: II. Empirical explorations of an evolutionary-developmental theory. Dev. Psychopathol. 2005, 17:303-328.
45. Fattaccini C.M., Bolanos-Jimenez F., Gozlan H., Hamon M. Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 1990, 29:1-8.
46. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., Hutton B. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 2005, 330:396.
47. Flinn M.V. Evolution and ontogeny of stress response to social challenges in the human child. Dev. Rev. 2006, 26:138-174.
48. Forbes E.E., Hariri A.R., Martin S.L., Silk J.S., Moyles D.L., Fisher P.M., Brown S.M., Ryan N.D., Birmaher B., Axelson D.A., Dahl R.E. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am. J. Psychiatry 2009, 166:64-73.
49. Frodl T., Reinhold E., Koutsouleris N., Donohoe G., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 2010.
50. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., Bottlender R., Schule C., Zwanzger P., Engel R.R., Rupprecht R., Bondy B., Reiser M., Moller H.J. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch. Gen. Psychiatry 2004, 61:177-183.
51. Fuchs E., Czeh B., Kole M.H., Michaelis T., Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur. Neuropsychopharmacol. 2004, 14(Suppl. 5):S481-S490.
52. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 1994, 55:163-167.
53. Garcia C., Chen M.J., Garza A.A., Cotman C.W., Russo-Neustadt A. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 2003, 119:721-732.
54. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
55. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999, 21:46S-51S.
56. Greenberg P.E., Kessler R.C., Birnbaum H.G., Leong S.A., Lowe S.W., Berglund P.A., Corey-Lisle P.K. The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 2003, 64:1465-1475.
57. Gunnell D., Saperia J., Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005, 330:385.
58. Gunthert K.C., Conner T.S., Armeli S., Tennen H., Covault J., Kranzler H.R. Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily life: a daily process approach to gene-environment interaction. Psychosom. Med. 2007, 69:762-768.
59. Hall W.D. How have the SSRI antidepressants affected suicide risk? Lancet 2006, 367:1959-1962.
60. Hayley S., Poulter M.O., Merali Z., Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005, 135:659-678.
61. Hellweg R., Zueger M., Fink K., Hortnagl H., Gass P. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol. Dis. 2007, 25:1-7.
62. Heninger G.R., Delgado P.L., Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 1996, 29:2-11.
63. Holmes A., Yang R.J., Murphy D.L., Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 2002, 27:914-923.
64. Holsboer F. How can we realize the promise of personalized antidepressant medicines? Nat. Rev. Neurosci. 2008, 9:638-646.
65. Huber R., Smith K., Delago A., Isaksson K., Kravitz E.A. Serotonin and aggressive motivation in crustaceans: altering the decision to retreat. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5939-5942.
66. Iversen L. The monoamine hypothesis of depression. Biology of Depression 2005, 71-86. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. J. Licinio, M.L. Wong (Eds.).
67. Ivy A.S., Rodriguez F.G., Garcia C., Chen M.J., Russo-Neustadt A.A. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol. Biochem. Behav. 2003, 75:81-88.
68. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 2005, 136:29-37.
69. Kato M., Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry 2010, 15:473-500.
70. Kaufman J., Yang B.Z., Douglas-Palumberi H., Houshyar S., Lipschitz D., Krystal J.H., Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17316-17321.
71. Kobayashi K., Ikeda Y., Sakai A., Yamasaki N., Haneda E., Miyakawa T., Suzuki H. Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8434-8439.
72. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
73. Lambert G., Johansson M., Agren H., Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch. Gen. Psychiatry 2000, 57:787-793.
74. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., Kunz D., Gallinat J. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berlin) 2005, 180:95-99.
75. Larson E.T., Summers C.H. Serotonin reverses dominant social status. Behav. Brain Res. 2001, 121:95-102.
76. Lesch K.P. Neuroticism and serotonin: a developmental genetic perspective. Behavioral Genetics in the Postgenomics Era 2003, 389-424. APA, Washington, DC. R. Plomin, J.C. DeFries, I.W. Craig, P. McGuffin (Eds.).
77. Lesch K.P. Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour. EMBO Rep. 8 Spec No. S24-29 2007.
78. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
79. Licinio J., Wong M.L. Biology of Depression 2005, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
80. Magarinos A.M., Deslandes A., McEwen B.S. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur. J. Pharmacol. 1999, 371:113-122.
81. Malagie I., Deslandes A., Gardier A.M. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur. J. Pharmacol. 2000, 403:55-65.
82. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
83. Malenka R.C. The long-term potential of LTP. Nat. Rev. Neurosci. 2003, 4:923-926.
84. Mamounas L.A., Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci. 2000, 20:771-782.
85. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat. Med. 2001, 7:541-547.
86. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3:e442.
87. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
88. Maya Vetencourt J.F., Sale A., Viegi A., Baroncelli L., De Pasquale R., O'Leary O.F., Castren E., Maffei L. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 2008, 320:385-388.
89. McEwen B.S., Olie J.P. Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol. Psychiatry 2005, 10:525-537.
90. McEwen B.S., Chattarji S., Diamond D.M., Jay T.M., Reagan L.P., Svenningsson P., Fuchs E. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol. Psychiatry 2010, 15:237-249.
91. Mennini T., Mocaer E., Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1987, 336:478-482.
92. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., Young T., Praschak-Rieder N., Wilson A.A., Houle S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch. Gen. Psychiatry 2006, 63:1209-1216.
93. Miczek K.A., de Almeida R.M., Kravitz E.A., Rissman E.F., de Boer S.F., Raine A. Neurobiology of escalated aggression and violence. J. Neurosci. 2007, 27:11803-11806.
94. Moncrieff J., Kirsch I. Efficacy of antidepressants in adults. BMJ 2005, 331:155-157.
95. Mössner R., Daniel S., Albert D., Heils A., Okladnova O., Schmitt A., Lesch K.-P. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem. Int. 2000, 36:197-202.
96. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
97. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
98. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
99. Normann C., Schmitz D., Furmaier A., Doing C., Bach M. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol. Psychiatry 2007, 62:373-380.
100. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13290-13295.
101. Pampallona S., Bollini P., Tibaldi G., Kupelnick B., Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch. Gen. Psychiatry 2004, 61:714-719.
102. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
103. Pineyro G., Deveault L., de Montigny C., Blier P. Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 351:119-125.
104. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
105. Pizzagalli D.A., Holmes A.J., Dillon D.G., Goetz E.L., Birk J.L., Bogdan R., Dougherty D.D., Iosifescu D.V., Rauch S.L., Fava M. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am. J. Psychiatry 2009, 166:702-710.
106. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 2007, 6:219-233.
107. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45:1085-1098.
108. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J. Neurosci. 2005, 25:6243-6250.
109. Risch N., Herrell R., Lehner T., Liang K.Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301:2462-2471.
110. Ruhe H.G., Mason N.S., Schene A.H. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 2007, 12:331-359.
111. Russo S., Kema I.P., Bosker F., Haavik J., Korf J. Tryptophan as an evolutionarily conserved signal to brain serotonin: molecular evidence and psychiatric implications. World J. Biol. Psychiatry 2009, 10:258-268.
112. Sairanen M., Lucas G., Ernfors P., Castren M., Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25:1089-1094.
113. Schinka J.A., Busch R.M., Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 2004, 9:197-202.
114. Schmitt A., Benninghoff J., Moessner R., Rizzi M., Paizanis E., Doenitz C., Gross S., Hermann M., Gritti A., Lanfumey L., Fritzen S., Reif A., Hamon M., Murphy D.L., Vescovi A., Lesch K.P. Adult neurogenesis in serotonin transporter deficient mice. J. Neural Transm. 2007, 114:1107-1119.
115. Schosser A., Kasper S. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int. Clin. Psychopharmacol. 2009, 24:277-288.
116. Scott J. Treatment of chronic depression. N. Engl. J. Med. 2000, 342:1518-1520.
117. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
118. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3908-3913.
119. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S., Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54:70-75.
120. Spolidoro M., Sale A., Berardi N., Maffei L. Plasticity in the adult brain: lessons from the visual system. Exp. Brain Res. 2009, 192:335-341.
121. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 2000, 157:1552-1562.
122. Taylor S.E., Way B.M., Welch W.T., Hilmert C.J., Lehman B.J., Eisenberger N.I. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol. Psychiatry 2006, 60:671-676.
123. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
124. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 2006, 163:28-40.
125. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
126. West-Eberhard M.J. Developmental Plasticity and Evolution 2003, Oxford University Press, New York.
127. Wilhelm K., Mitchell P.B., Niven H., Finch A., Wedgwood L., Scimone A., Blair I.P., Parker G., Schofield P.R. Life events, first depression onset and the serotonin transporter gene. Br. J. Psychiatry 2006, 188:210-215.
128. Wilkinson M.B., Xiao G., Kumar A., LaPlant Q., Renthal W., Sikder D., Kodadek T.J., Nestler E.J. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 2009, 29:7820-7832.
129. Wilson C.C., Faber K.M., Haring J.H. Serotonin regulates synaptic connections in the dentate molecular layer of adult rats via 5-HT1a receptors: evidence for a glial mechanism. Brain Res. 1998, 782:235-239.
130. Wirz-Justice A., Benedetti F., Berger M., Lam R.W., Martiny K., Terman M., Wu J.C. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol. Med. 2005, 35:939-944.
131. Wong M.L., Licinio J. Research and treatment approaches to depression. Nat. Rev. Neurosci. 2001, 2:343-351.
132. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry 2006, 163:1588-1593.
133. Zetterström T.S.C., Pei Q., Madhav T.R., Coppell A.L., Lewis L., Grahame-Smith D.G. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 1999, 38:1063-1073.